40
Participants
Start Date
November 30, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
March 31, 2012
Fluzone® Intradermal (Sanofi Pasteur Inc.)
"Fluzone® Intradermal trivalent vaccine is a clear-to-slightly opalescent, preservative-free suspension containing formaldehyde-inactivated split influenza viruses for intradermal delivery of 0.1 mL via an ultra-fine micro-needle. The vaccine is supplied as a single-dose, in a latex-free, pre-filled microinjection system. The active substance is prepared from influenza viruses propagated in embryonated chicken eggs.~Fluzone® Intradermal is standardized according to United States Public Health Service (US PHS) requirements and is formulated to contain HA of each of the following three influenza strains recommended for the 2011-2012 influenza season: A/California/07/2009 X-179A (H1N1)-like virus, A/Perth/16/2009 (H3N2)-like virus, and B/Brisbane/60/2008-like virus."
National Jewish Health, Denver
Atopic Dermatitis Research Network
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH